Accessibility settings

Published on in Vol 14 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/73926, first published .
Close-up of a baby girl with curly hair looking at the camera, bathed in sunlight.

Feasibility, Safety, and Impact of the Probiotics Lactiplantibacillus plantarum and Bifidobacterium longum subspecies infantis in Papua New Guinean Infants: Protocol for a Randomized Controlled Trial

Feasibility, Safety, and Impact of the Probiotics Lactiplantibacillus plantarum and Bifidobacterium longum subspecies infantis in Papua New Guinean Infants: Protocol for a Randomized Controlled Trial

Rebecca L Ford   1 , PhD ;   Andrew R Greenhill   2 , PhD ;   Joycelyn Sapura   1 , DipHS(RH) ;   Amelia Koata   1 , DipN ;   Mary Dreyam   1 , DipN ;   Tilda Orami   1 , BSc ;   Joe Jude   1 , BSc ;   Madeline Ong   3 , MD ;   Wendy Kirarock   1 , BSc ;   Dorcas Joseph   1 , Cert OA ;   Geraldine Masiria   1 , BHS(RH) ;   Celestine Aho   1 , PhD ;   William S Pomat   1 , PhD ;   Anita H J van den Biggelaar   3, 4 , PhD ;   Peter C Richmond   3, 5 , MBBS

1 Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea

2 Microbiology Research Group, Institute of Innovation, Science and Sustainability, Federation University, Churchill, Australia

3 Wesfarmers Centre for Vaccines and Infectious Diseases, The Kids Research Institute Australia, Perth, Australia

4 Centre for Child Health Research, University of Western Australia, Perth, Australia

5 Discipline of Paediatrics, Medical School, University of Western Australia, Perth, Australia

Corresponding Author:

  • Rebecca L Ford, PhD
  • Papua New Guinea Institute of Medical Research
  • PO Box 60
  • Cnr of Homate & Leigh Vial Streets
  • Goroka EHP 441
  • Papua New Guinea
  • Phone: 675 532 2800
  • Fax: 675 532 1998
  • Email: rebecca.ford.imr@gmail.com